This is to acknowledge that on February 19, 2019 the Market Regulation Department of the Financial Industry Regulatory Authority (FINRA) received your complaint regarding trading activity in Oncolix Inc. (“ONCX”). We will use the information you provided regarding ONCX in the scope of our regulatory programs designed to determine whether violations of federal securities laws or FINRA or other rules have occurred. While the reviews conducted by the Market Regulation Department are confidential and non-public, the staff may contact you if deemed appropriate as it carries out its responsibilities with regard to your concerns.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.